Medtech
AI-Integrated Smart Medical Devices, Remote Patient Monitoring
Medtech's most important 2026 trend is the integration of AI into medical devices for real-time diagnostics, surgical instruments made intelligent with AI decision support, and enhanced medical imaging. Medtech companies are also creating biodegradable smart implants and AI-powered robotic surgery systems for unprecedented precision and patient outcomes.
Companies Leading This Trend
- Medtronic – AI-integrated surgical instruments with real-time decision support; smart pacemakers that adjust according to patient activity; and remote patient monitoring systems that use ML to predict health episodes.
- Philips – AI-powered medical imaging systems with quantum sensing tech, smart hospital platforms to predict patient flow, and telehealth solutions that provide real-time diagnostics and remote monitoring capabilities.
Considering a Medtech Company Sale or Purchase?
Kuhn Capital's principals have initiated over 80 mid-market technology transactions worth more than $3 billion. We advise medical technology and device companies on sellside, buyside, and strategic advisory engagements. To discuss yours, email us or call (650) 353-3353.
Standard three changes, bullets untouched. Five left: Manufacturing, Publishing, Software, Tech Services, Teletech.
Infection control vendor Cardeya retained a Kuhn Capital team member to provide strategic advisory services
Strategic Advisory
Protom, manufacturer of miniature medical therapy synchrotrons, retained a Kuhn Capital team member to provide strategic advisory services
Strategic Advisory
Kuhn Capital team members provided strategic advisory services to FlintRehab, maker of stroke recovery systems
Strategic Advisory
Biopharma data management vendor IDBS retained a Kuhn Capital team member to initiate its acquisition by Danaher
Sellside
Ricon, manufacturer of mobility tools, retained a Kuhn Capital team member to initiate its acquisition by PE firm Apax
$50,000,000
Sellside